 |
|
|
|
| |
|
|
|
|
|
Room for Review was published
in November 2002.
In 2004, Medicines Partnership commissioned
an evaluation of the impact of Room for Review from
Webstar Health Ltd, which is available to download
below.
The objectives of the evaluation were:
- To determine the extent to which
the framework set out in Room for Review has been
adopted as a standard for the introduction and implementation
of medication reviews by PCTs
- To determine the degree to which
Room for Review has encouraged and assisted the
development of patient-centred services by managers
commissioning medication review services and clinicians
delivering medication review services
- To describe the perception of
patients of their experience of medication reviews
since the publication of Room for Review
Ultimately, the key question resonating
throughout the evaluation was to what extent Room
for Review had resulted in improved availability of
patient centred, face to face medication review.
The evaluation was conducted using
a combination of qualitative and quantitative methods.
- The views of PCT stakeholders
were collected through a one-day workshop
and by a pre-piloted self-completion survey
distributed via the National Prescribing
Centre to PCT Pharmaceutical Advisors. A total of
153 responses (50.1%) were received and these were
broadly representative when compared to PCTs participating
in the NPC's Medicines Management Collaborative.
- The opinions of various organisations
and policy groups involved in medication review
were collected through a series of stakeholder
interviews.
- Five focus groups
were conducted with patients who had received
a face-to-face medication review since the publication
of Room for Review.
The results of the workshop, survey
and stakeholder interviews are contained in part 1
of the evaluation, published on 21st March 2005.
A second report, with results of the patient focus
groups, was published on 5th December 2005.
It was necessary to obtain Local Research Ethics Committee
approval before proceeding with the focus groups and
the additional time required for this approval significantly
delayed the publication of the second report and executive
briefing.
|
|
|
|
| |
|
|
|
|
|
|
|
|
